In line with this, the expressions of cyclin D1 and cycle-dependent kinase CDK4 were also significantly downregulated with licoricidin treatment, which promotes the exit of tumor cells from cell cycle and inhibition of cancer proliferation. The gene discussed is CCND1; the disease is neoplasm.